Tested Applications
| Positive IHC detected in | human heart tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
10907-1-AP targets TIMM10B in IHC, IF, ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag1355 Product name: Recombinant human FXC1 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-103 aa of BC011014 Sequence: MERQQQQQQQLRNLRDFLLVYNRMTELCFQRCVPSLHHRALDAEEEACLHSCAGKLIHSNHRLMAAYVQLMPALVQRRIADYEAASAVPSVAAEQPGVSPSGS Predict reactive species |
| Full Name | fracture callus 1 homolog (rat) |
| Calculated Molecular Weight | 12 kDa |
| GenBank Accession Number | BC011014 |
| Gene Symbol | TIMM10B |
| Gene ID (NCBI) | 26515 |
| RRID | AB_2105508 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q9Y5J6 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for TIMM10B antibody 10907-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The TIMM10B Polyclonal antibody (Cat# 10907-1-AP) has 1 citation to date. It was cited in Frontiers in Immunology (2025), in a study identifying tumor-associated neutrophil-related genes in triple-negative breast cancer for prognosis and therapeutic response prediction using integrated single-cell analysis. The cited application is immunofluorescence (IF) in human samples, placing the research within the fields of cancer immunology and breast oncology.
| Species | Application | Title |
|---|---|---|
Front Immunol Identification of tumor associated neutrophils-related genes in triple-negative breast cancer for predicting prognosis and therapeutic response through integrated single-cell analysis. |
